Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis

BACKGROUND AND AIM: Transarterial chemoembolization (TACE) represents a standard of care for patients with intermediate‐stage hepatocellular carcinoma (HCC) or liver metastases. However, identification of the ideal candidates for TACE therapy remains challenging. The soluble urokinase plasminogen ac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Loosen, Sven H, Schulze‐Hagen, Max, Vucur, Mihael, Gorgulho, Joao, Paffenholz, Pia, Benz, Fabian, Mohr, Raphael, Demir, Münevver, Wree, Alexander, Kuhl, Christiane, Trautwein, Christian, Tacke, Frank, Bruners, Philipp, Luedde, Tom, Roderburg, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936623/
https://ncbi.nlm.nih.gov/pubmed/33732882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados